1. Human plasma cell-free DNA as a predictor of infectious complications of neutropenic fever in hematological patients.
- Author
-
Purhonen AK, Juutilainen A, Vänskä M, Lehtikangas M, Lakkisto P, Hämäläinen S, Koivula I, Jantunen E, and Pulkki K
- Subjects
- Adolescent, Adult, Aged, Antineoplastic Agents adverse effects, Antineoplastic Agents therapeutic use, Biomarkers blood, Female, Hematologic Neoplasms drug therapy, Humans, Male, Middle Aged, Young Adult, Chemotherapy-Induced Febrile Neutropenia complications, Chemotherapy-Induced Febrile Neutropenia epidemiology, DNA blood, Hematologic Neoplasms complications, Hematologic Neoplasms epidemiology, Sepsis blood, Sepsis complications, Sepsis epidemiology
- Abstract
Neutropenic fever is common in patients receiving intensive chemotherapy for hematological malignancies. The clinical course may be aggravated by infectious complications like severe sepsis, septic shock or even death. We prospectively studied 100 patients with neutropenic fever and evaluated human plasma cell-free DNA (cfDNA) during the first 3 days after the onset of fever as a prognostic biomarker for complicated clinical course, defined as sepsis or septic shock. Complicated course was observed in 21 patients (21%). There were no significant differences in cfDNA levels between the patients with or without complications on any study day when all the patients were analyzed as one group. In subgroups according to hematological malignancy, patients with acute myeloid leukemia (AML) had lower cfDNA levels than patients with lymphoma. Among AML patients d0 cfDNA/leukocyte ratio and among lymphoma patients d0 cfDNA was associated with subsequent development of sepsis or septic shock. cfDNA deserves further studies in hematological patients with sepsis.
- Published
- 2015
- Full Text
- View/download PDF